By Sahar Chmais

Pfizer-BioNTech’s COVID-19 vaccine is the first to receive FDA approval for individuals ages 16 and older, according to the FDA.

Pfizer’s vaccine will be marketed under the name Comirnaty.

The FDA gave its approval only to Comirnaty for certain age groups, but the vaccine will still be provided to individuals aged 12-15, under the Emergency Use Authorization (EUA).

“While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency u...